Sino Total Revenue vs Net Income From Continuing Ops Analysis

688108 Stock

11.00 0.21 1.87%

Sino Medical financial indicator trend analysis is much more than just breaking down Sino Medical Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sino Medical Sciences is a good investment. Please check the relationship between Sino Medical Total Revenue and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sino Medical Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Revenue vs Net Income From Continuing Ops

Total Revenue vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sino Medical Sciences Total Revenue account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong relationship.

The correlation between Sino Medical's Total Revenue and Net Income From Continuing Ops is 0.72. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Sino Medical Sciences, assuming nothing else is changed. The correlation between historical values of Sino Medical's Total Revenue and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Sino Medical Sciences are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Total Revenue i.e., Sino Medical's Total Revenue and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.72

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Total Revenue

Total revenue comprises all receipts Sino Medical Sciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Net Income From Continuing Ops

Most indicators from Sino Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sino Medical Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sino Medical Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Tax Provision is expected to grow to about (23.2 M). In addition to that, Selling General Administrative is expected to decline to about 82.7 M

	2021	2022	2023	2024 (projected)
Gross Profit	143.5M	121.7M	202.2M	190.1M
Total Revenue	194.4M	192.9M	343.3M	246.2M

Gross Profit Total Revenue

Sino Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Non Current Liabilities Other	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Shares Outstanding
Total Assets		-0.58	0.78	0.99	0.92	1.0	0.04	0.83	0.83	0.88	0.45	0.87	-0.64	0.61	0.91	0.7	-0.1	0.72	0.91	0.63	0.85	0.35	0.94	0.98	0.92	0.84
Other Current Liab	-0.58		-0.35	-0.57	-0.45	-0.61	-0.06	-0.44	-0.58	-0.38	-0.69	-0.34	0.27	-0.64	-0.44	-0.32	0.05	-0.47	-0.39	-0.41	-0.64	0.03	-0.42	-0.56	-0.39	-0.57
Total Current Liabilities	0.78	-0.35		0.68	0.79	0.73	-0.52	0.83	0.34	0.92	0.67	0.94	-0.8	0.77	0.93	0.4	-0.03	0.95	0.91	0.87	0.39	-0.08	0.88	0.83	0.89	0.87
Total Stockholder Equity	0.99	-0.57	0.68		0.88	0.99	0.17	0.78	0.89	0.8	0.36	0.79	-0.55	0.52	0.84	0.72	-0.1	0.6	0.84	0.53	0.91	0.44	0.89	0.95	0.86	0.76
Other Liab	0.92	-0.45	0.79	0.88		0.89	-0.07	0.73	0.69	0.92	0.43	0.89	-0.75	0.64	0.89	0.84	-0.28	0.77	0.92	0.65	0.66	0.43	0.96	0.92	0.94	0.86
Net Tangible Assets	1.0	-0.61	0.73	0.99	0.89		0.12	0.81	0.87	0.83	0.42	0.82	-0.57	0.56	0.87	0.68	-0.06	0.67	0.87	0.58	0.89	0.38	0.91	0.97	0.88	0.8
Retained Earnings	0.04	-0.06	-0.52	0.17	-0.07	0.12		-0.23	0.47	-0.34	-0.67	-0.34	0.63	-0.65	-0.31	0.23	0.05	-0.53	-0.27	-0.73	0.45	0.74	-0.2	-0.07	-0.23	-0.41
Accounts Payable	0.83	-0.44	0.83	0.78	0.73	0.81	-0.23		0.59	0.83	0.51	0.84	-0.67	0.62	0.89	0.44	0.11	0.74	0.85	0.69	0.59	0.07	0.83	0.89	0.83	0.71
Cash	0.83	-0.58	0.34	0.89	0.69	0.87	0.47	0.59		0.51	0.16	0.49	-0.24	0.28	0.58	0.64	0.12	0.29	0.57	0.25	0.95	0.55	0.66	0.77	0.6	0.53
Non Current Assets Total	0.88	-0.38	0.92	0.8	0.92	0.83	-0.34	0.83	0.51		0.56	0.99	-0.88	0.74	0.99	0.59	-0.21	0.9	0.99	0.8	0.5	0.11	0.98	0.93	0.99	0.92
Non Currrent Assets Other	0.45	-0.69	0.67	0.36	0.43	0.42	-0.67	0.51	0.16	0.56		0.53	-0.66	0.96	0.58	0.11	-0.03	0.74	0.51	0.87	0.21	-0.52	0.5	0.51	0.49	0.75
Other Assets	0.87	-0.34	0.94	0.79	0.89	0.82	-0.34	0.84	0.49	0.99	0.53		-0.85	0.7	0.99	0.54	-0.15	0.91	0.99	0.79	0.48	0.09	0.97	0.92	0.99	0.9
Net Receivables	-0.64	0.27	-0.8	-0.55	-0.75	-0.57	0.63	-0.67	-0.24	-0.88	-0.66	-0.85		-0.83	-0.83	-0.48	0.36	-0.81	-0.84	-0.88	-0.2	0.15	-0.82	-0.72	-0.84	-0.85
Non Current Liabilities Total	0.61	-0.64	0.77	0.52	0.64	0.56	-0.65	0.62	0.28	0.74	0.96	0.7	-0.83		0.74	0.32	-0.15	0.83	0.69	0.94	0.3	-0.36	0.69	0.67	0.68	0.88
Inventory	0.91	-0.44	0.93	0.84	0.89	0.87	-0.31	0.89	0.58	0.99	0.58	0.99	-0.83	0.74		0.54	-0.08	0.9	0.99	0.81	0.57	0.08	0.98	0.96	0.98	0.92
Other Current Assets	0.7	-0.32	0.4	0.72	0.84	0.68	0.23	0.44	0.64	0.59	0.11	0.54	-0.48	0.32	0.54		-0.53	0.36	0.59	0.28	0.61	0.75	0.68	0.65	0.64	0.5
Other Stockholder Equity	-0.1	0.05	-0.03	-0.1	-0.28	-0.06	0.05	0.11	0.12	-0.21	-0.03	-0.15	0.36	-0.15	-0.08	-0.53		-0.09	-0.14	-0.02	0.05	-0.28	-0.16	-0.05	-0.19	-0.1
Total Liab	0.72	-0.47	0.95	0.6	0.77	0.67	-0.53	0.74	0.29	0.9	0.74	0.91	-0.81	0.83	0.9	0.36	-0.09		0.88	0.85	0.3	-0.15	0.84	0.8	0.87	0.91
Deferred Long Term Liab	0.91	-0.39	0.91	0.84	0.92	0.87	-0.27	0.85	0.57	0.99	0.51	0.99	-0.84	0.69	0.99	0.59	-0.14	0.88		0.76	0.56	0.16	0.99	0.95	1.0	0.91
Short Long Term Debt	0.63	-0.41	0.87	0.53	0.65	0.58	-0.73	0.69	0.25	0.8	0.87	0.79	-0.88	0.94	0.81	0.28	-0.02	0.85	0.76		0.27	-0.36	0.75	0.7	0.74	0.89
Total Current Assets	0.85	-0.64	0.39	0.91	0.66	0.89	0.45	0.59	0.95	0.5	0.21	0.48	-0.2	0.3	0.57	0.61	0.05	0.3	0.56	0.27		0.52	0.64	0.76	0.57	0.5
Non Current Liabilities Other	0.35	0.03	-0.08	0.44	0.43	0.38	0.74	0.07	0.55	0.11	-0.52	0.09	0.15	-0.36	0.08	0.75	-0.28	-0.15	0.16	-0.36	0.52		0.25	0.26	0.21	-0.05
Intangible Assets	0.94	-0.42	0.88	0.89	0.96	0.91	-0.2	0.83	0.66	0.98	0.5	0.97	-0.82	0.69	0.98	0.68	-0.16	0.84	0.99	0.75	0.64	0.25		0.97	0.99	0.91
Common Stock	0.98	-0.56	0.83	0.95	0.92	0.97	-0.07	0.89	0.77	0.93	0.51	0.92	-0.72	0.67	0.96	0.65	-0.05	0.8	0.95	0.7	0.76	0.26	0.97		0.95	0.87
Property Plant Equipment	0.92	-0.39	0.89	0.86	0.94	0.88	-0.23	0.83	0.6	0.99	0.49	0.99	-0.84	0.68	0.98	0.64	-0.19	0.87	1.0	0.74	0.57	0.21	0.99	0.95		0.91
Common Stock Shares Outstanding	0.84	-0.57	0.87	0.76	0.86	0.8	-0.41	0.71	0.53	0.92	0.75	0.9	-0.85	0.88	0.92	0.5	-0.1	0.91	0.91	0.89	0.5	-0.05	0.91	0.87	0.91

Click cells to compare fundamentals

Sino Medical Account Relationship Matchups

Sino Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.2B	1.2B	1.1B	1.1B	1.2B	1.0B
Other Current Liab	6.3M	8.7M	12.0M	35.5M	137.0K	130.1K
Total Current Liabilities	79.2M	92.2M	92.6M	132.2M	151.3M	107.5M
Total Stockholder Equity	1.1B	1.1B	927.8M	847.1M	820.0M	863.8M
Other Liab	27.9M	47.5M	37.9M	36.1M	41.5M	31.7M
Net Tangible Assets	1.1B	993.2M	853.9M	794.2M	913.3M	800.5M
Retained Earnings	140.8M	122.3M	(8.4M)	(161.3M)	(234.7M)	(223.0M)
Accounts Payable	21.1M	20.1M	23.4M	28.4M	28.2M	25.0M
Cash	638.4M	544.7M	287.8M	203.4M	188.6M	328.5M
Non Current Assets Total	398.7M	494.1M	672.3M	712.7M	841.6M	511.6M
Non Currrent Assets Other	9.1M	6.3M	14.9M	3.1M	134.2M	140.9M
Other Assets	241.0M	265.3M	392.1M	464.1M	533.7M	268.5M
Net Receivables	86.1M	65.0M	11.2M	20.3M	8.9M	8.5M
Non Current Liabilities Total	27.9M	47.5M	65.4M	47.9M	172.9M	181.5M
Inventory	68.4M	64.7M	84.9M	98.1M	118.2M	74.4M
Other Current Assets	5.9M	46.5M	28.4M	15.6M	8.9M	16.9M
Other Stockholder Equity	2.4M	309.8K	(1.1M)	1.5M	1.4M	800.0K
Total Liab	107.1M	139.6M	157.9M	180.1M	324.2M	164.4M
Deferred Long Term Liab	236.0M	253.1M	333.1M	369.2M	424.6M	235.0M
Total Current Assets	806.9M	723.4M	430.8M	354.9M	344.2M	530.2M
Non Current Liabilities Other	12.0M	27.4M	14.5M	11.4M	1.5M	1.4M
Intangible Assets	257.5M	309.3M	321.0M	354.5M	378.1M	271.5M
Property Plant Equipment	116.4M	139.2M	172.6M	176.8M	203.3M	117.2M
Net Invested Capital	1.1B	1.1B	944.6M	893.6M	939.5M	984.4M
Net Working Capital	727.7M	631.3M	338.2M	222.7M	192.9M	341.4M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Sino Stock

Balance Sheet is a snapshot of the financial position of Sino Medical Sciences at a specified time, usually calculated after every quarter, six months, or one year. Sino Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sino Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sino currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sino Total Revenue vs Net Income From Continuing Ops Analysis

Total Revenue vs Net Income From Continuing Ops

Total Revenue vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Total Revenue

Net Income From Continuing Ops

Sino Medical fundamental ratios Correlations

Sino Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sino Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Sino Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Assets
Property Plant Equipment	+ 1.0	Deferred Long Term Liab
Total Stockholder Equity	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Other Assets	+ 0.99	Non Current Assets Total
Inventory	+ 0.99	Non Current Assets Total

Short Long Term Debt	- 0.88	Net Receivables
Net Receivables	- 0.88	Non Current Assets Total
Common Stock Shares Outstanding	- 0.85	Net Receivables
Net Receivables	- 0.85	Other Assets
Property Plant Equipment	- 0.84	Net Receivables
Deferred Long Term Liab	- 0.84	Net Receivables